Thermo Fisher Scientific Inc. (NYSE:TMO) Stock Holdings Raised by J. Safra Sarasin Holding AG

Key Points

• J. Safra Sarasin Holding AG increased its stake in Thermo Fisher Scientific by 2.5%, owning a total of 35,255 shares valued at approximately $17.54 million.
• Thermo Fisher's latest quarterly earnings surpassed expectations, with a reported earnings per share of $5.36 and revenues of $10.86 billion.
• The company will pay a quarterly dividend of $0.43 per share on October 15th, resulting in an annualized dividend yield of 0.4%.

J. Safra Sarasin Holding AG grew its holdings in Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) by 2.5% in the first quarter, according to its most recent disclosure with the SEC. The fund owned 35,255 shares of the medical research company's stock after buying an additional 844 shares during the period. J. Safra Sarasin Holding AG's holdings in Thermo Fisher Scientific were worth $17,544,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. Malaga Cove Capital LLC increased its stake in shares of Thermo Fisher Scientific by 44.7% during the first quarter. Malaga Cove Capital LLC now owns 2,492 shares of the medical research company's stock worth $1,240,000 after acquiring an additional 770 shares during the period. Pathway Financial Advisers LLC increased its stake in shares of Thermo Fisher Scientific by 4.1% during the first quarter. Pathway Financial Advisers LLC now owns 1,385 shares of the medical research company's stock worth $689,000 after acquiring an additional 55 shares during the period. Banco Santander S.A. increased its stake in shares of Thermo Fisher Scientific by 14.0% during the first quarter. Banco Santander S.A. now owns 87,286 shares of the medical research company's stock worth $43,434,000 after acquiring an additional 10,714 shares during the period. United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund increased its stake in shares of Thermo Fisher Scientific by 7.6% during the first quarter. United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund now owns 111,210 shares of the medical research company's stock worth $55,338,000 after acquiring an additional 7,814 shares during the period. Finally, PNC Financial Services Group Inc. increased its stake in shares of Thermo Fisher Scientific by 0.6% during the first quarter. PNC Financial Services Group Inc. now owns 272,053 shares of the medical research company's stock worth $135,374,000 after acquiring an additional 1,591 shares during the period. 89.23% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on TMO shares. Stifel Nicolaus lowered their target price on shares of Thermo Fisher Scientific from $665.00 to $620.00 and set a "buy" rating on the stock in a research report on Thursday, April 24th. Barclays upped their target price on shares of Thermo Fisher Scientific from $450.00 to $490.00 and gave the stock an "equal weight" rating in a research report on Thursday, July 24th. Evercore ISI lowered their target price on shares of Thermo Fisher Scientific from $500.00 to $480.00 and set an "outperform" rating on the stock in a research report on Tuesday, July 8th. HSBC reaffirmed a "hold" rating and issued a $510.00 price target on shares of Thermo Fisher Scientific in a report on Thursday, July 24th. Finally, Robert W. Baird upped their price target on shares of Thermo Fisher Scientific from $553.00 to $567.00 and gave the company an "outperform" rating in a report on Thursday, July 24th. Six research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $593.00.

Insider Transactions at Thermo Fisher Scientific

In other news, EVP Gianluca Pettiti sold 400 shares of the business's stock in a transaction dated Friday, July 25th. The shares were sold at an average price of $479.98, for a total value of $191,992.00. Following the completion of the sale, the executive vice president owned 22,367 shares of the company's stock, valued at approximately $10,735,712.66. The trade was a 1.76% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 0.33% of the stock is owned by company insiders.

Thermo Fisher Scientific Trading Down 1.1%

Shares of Thermo Fisher Scientific stock traded down $4.94 during trading hours on Friday, hitting $462.74. The company's stock had a trading volume of 2,756,840 shares, compared to its average volume of 3,361,249. Thermo Fisher Scientific Inc. has a 1-year low of $385.46 and a 1-year high of $627.88. The business has a fifty day moving average of $420.88 and a 200 day moving average of $466.41. The company has a market capitalization of $174.68 billion, a PE ratio of 26.76, a P/E/G ratio of 2.47 and a beta of 0.74. The company has a quick ratio of 1.50, a current ratio of 1.93 and a debt-to-equity ratio of 0.65.

Thermo Fisher Scientific (NYSE:TMO - Get Free Report) last released its quarterly earnings results on Wednesday, July 23rd. The medical research company reported $5.36 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.22 by $0.14. Thermo Fisher Scientific had a net margin of 15.24% and a return on equity of 16.82%. The firm had revenue of $10.86 billion for the quarter, compared to the consensus estimate of $10.68 billion. During the same quarter in the previous year, the firm posted $5.37 EPS. The firm's quarterly revenue was up 2.9% on a year-over-year basis. As a group, equities analysts forecast that Thermo Fisher Scientific Inc. will post 23.28 EPS for the current year.

Thermo Fisher Scientific Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Monday, September 15th will be paid a dividend of $0.43 per share. The ex-dividend date of this dividend is Monday, September 15th. This represents a $1.72 annualized dividend and a yield of 0.4%. Thermo Fisher Scientific's payout ratio is 9.95%.

Thermo Fisher Scientific Profile

Thermo Fisher Scientific Inc provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.